Phase 4 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 60 years or older
- People who have been newly diagnosed with invasive breast cancer in one breast only, confirmed by a tissue sample test
- People whose cancer tests show HER-2 positive status (a specific protein found on cancer cells, confirmed by laboratory testing)
- People whose cancer is at a specific stage — broadly described as stage II or IIIA, based on the size of the tumour and whether nearby lymph nodes are affected, but not spread to distant parts of the body (confirm exact staging details with the trial site)
- People who have at least one measurable area of cancer that doctors can track during treatment
- People who are generally able to carry out daily activities with no or only minor limitations (this is measured using a standard scale called the ECOG score of 0 or 1)
- People whose blood test results show the blood cells and immune system are working within acceptable levels, without needing recent blood transfusions or growth factor treatments
- People whose liver and kidney function blood test results are within acceptable ranges
- People whose heart is pumping blood effectively, with the heart's pumping strength (called LVEF) measured at 50% or above
- People who are willing to take part, sign a consent form, follow the study requirements, and attend follow-up appointments
Who may not be able to join:
- People with certain specific types of breast cancer, including hidden (occult) breast cancer, inflammatory breast cancer, or a type affecting the skin around the nipple (eczematous carcinoma)
- People with a known allergy to any ingredient in the study medication
- People with serious heart problems that are expected to make chemotherapy unsafe, including certain abnormal heart rhythms, unstable chest pain (angina), significant heart valve disease, or evidence of a full-thickness heart attack on heart scans
- People with severe or uncontrolled infections that could interfere with the study, including active hepatitis virus infection, HIV, lung infections, or similar conditions
- People who have had another type of cancer in the past 5 years (some exceptions may apply, such as certain fully treated skin or cervical conditions — confirm with the trial site)
- People who have taken part in another clinical trial within the 4 weeks before joining this study
- People where the trial doctor believes there is any other reason participation would not be appropriate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613588054604
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathological complete remission rate in breast cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.